ReviewCancer drug resistance (Alhambra, Calif.)2025
Targeting the hypoxia signaling pathway with nanomedicine to reverse immunotherapy resistance.
Xiaoliang Cheng et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
8 papers cite it
this papercites it